Global Intravenous (IV) Iron Drugs Market Professional Survey Report 2019
Iron infusion is a procedure in which iron is delivered to your body intravenously, meaning into a vein through a needle. This method of delivering medication or supplementation is also known as an intravenous (IV) infusion. Iron infusions are usually prescribed by doctors to treat iron deficiency anemia.
Iron is one of the most important mineral present inside the human body. It carries oxygen throughout the body via the blood, which is further utilized by cells and tissue to get energy for all vital biological processes. Moreover, deficiency of iron leads to severe health problems, such as anemia and also affects mental or other memory functions in youths. To overcome this problem, oral iron supplements are recommended to maintain the iron level in the body. However, in some cases, oral administrations are not capable of maintaining the iron level in the body. For these cases, IV iron therapy is used to as part of which iron is directly injected inside the body with a needle through a vein.
The global Intravenous (IV) Iron Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Intravenous (IV) Iron Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Intravenous (IV) Iron Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Intravenous (IV) Iron Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Intravenous (IV) Iron Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Sanofi
Allergan
AMAG Pharmaceuticals
Dalichi Sankyo
Luitpold Pharmaceuticals
Pharmacosmos
Takeda Pharmaceutical
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Ferric Carboxymaltose
Iron Sucrose
Iron Dextran
Others
Segment by Application
Nephrology
Gynecology & Obstetrics
Gastroenterology
Oncology
Cardiology
Others
Iron is one of the most important mineral present inside the human body. It carries oxygen throughout the body via the blood, which is further utilized by cells and tissue to get energy for all vital biological processes. Moreover, deficiency of iron leads to severe health problems, such as anemia and also affects mental or other memory functions in youths. To overcome this problem, oral iron supplements are recommended to maintain the iron level in the body. However, in some cases, oral administrations are not capable of maintaining the iron level in the body. For these cases, IV iron therapy is used to as part of which iron is directly injected inside the body with a needle through a vein.
The global Intravenous (IV) Iron Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Intravenous (IV) Iron Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Intravenous (IV) Iron Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Intravenous (IV) Iron Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Intravenous (IV) Iron Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Sanofi
Allergan
AMAG Pharmaceuticals
Dalichi Sankyo
Luitpold Pharmaceuticals
Pharmacosmos
Takeda Pharmaceutical
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Ferric Carboxymaltose
Iron Sucrose
Iron Dextran
Others
Segment by Application
Nephrology
Gynecology & Obstetrics
Gastroenterology
Oncology
Cardiology
Others
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
